XML 77 R55.htm IDEA: XBRL DOCUMENT v3.25.0.1

Note 10 - Equity (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2024

Dec. 31, 2023

Notes Tables

Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]

		Number of Warrants				Weighted Average Exercise Price				Weighted Average Remaining Life
Outstanding warrants, January 1, 2024			193,433			$	23.46				2.74
Series C Warrants (Note 10.a)			86,820				24.62
Broker warrants for Series C Offering (Note 10.a)			4,163				12.31
PIPE Warrants (Note 10.a)			823,529				6.83
WaveDancer legacy warrants (Note 4)			76,098				94.69
Outstanding warrants, September 30, 2024			1,184,043			$	16.51				4.06

		Number of Warrants				Weighted Average Remaining Life
Outstanding warrants, January 1, 2024			54,782				1.51
Pre-funded warrants (Note 10.a)			504,324
Series A warrants (Note 10.d)			629,039
Series D warrants (Note 10.e)			92,798
Consulting agreement warrants (Note 10.f)			44,932
Exercised			(435,169	)
Outstanding warrants, September 30, 2024			890,706				3.48

		Number of Warrants				Weighted Average Exercise Price				Weighted Average Remaining Life
Outstanding warrants, January 1, 2022			12,827			$	72.12				0.85
Warrants issued pursuant to issue of convertible debt and preferred shares to individual investors			20,642				28.85
Warrants issued pursuant to modification of convertible debt			54,782				7.21
Outstanding warrants, December 31, 2022			88,251			$	21.73				2.50
Warrants issued pursuant to units offering			159,964				24.62
Outstanding warrants, December 31, 2023			248,215			$	19.90				2.46

Share-Based Payment Arrangement, Option, Activity [Table Text Block]

		Number of Stock Options				Weighted Average Exercise Price				Weighted Average Remaining Contractual Term (Years)				Aggregate Intrinsic Value
Outstanding Options, December 31, 2023			134,333			$	20.77				6.18			$	-
Options granted			335,728				5.18				-				-
WaveDancer options			113,522				82.25				-				-
Outstanding Options, September 30, 2024			583,583			$	23.77				3.43			$	-

		Number of Stock Options				Weighted Average Grant- Date Fair Value
Non-Vested Options, December 31, 2023			90,988			$	4.77
Options granted			335,728				4.77
Options vested			(185,704	)			4.94
Non-Vested Options, September 30, 2024			241,012			$	4.63

		Number of Stock Options				Weighted Average Exercise Price				Weighted Average Remaining Contractual Term				Aggregate Intrinsic Value
Outstanding Options, December 31, 2022			51,558			$	45.19				6.90			$	-
Options granted			82,775				5.58
Outstanding Options, December 31, 2023			134,333			$	20.77				6.18			$	-

		Number of Stock Options				Weighted Average Grant- Date Fair Value
Non-Vested Options, December 31, 2022			33,889			$	21.15
Options granted			82,775				0.00
Options vested			(25,676	)			11.06
Non-Vested Options, December 31, 2023			90,988			$	4.77

Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

		2024
Stock price			$6.91
Risk free rate		3.75%	-	3.82%
Dividend yield			0%
Expected volatility		86.50%	-	87.60%
Expected term (in years)		3.91	-	4.93

		2023				2022
Risk free rate			4.35	%			4.5	%
Dividend yield			0	%			0	%
Expected volatility			86	%			86	%
Expected term (in years)			3				3
Expected life (in years)			5				5

Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]

		Three months ended September 30,								Nine months ended September 30,
		2024				2023				2024				2023
Employees stock options		$	1,296			$	78			$	1,413			$	226
Restricted share units			410				-				410				-
Series D warrants			610				-				610				-
Total		$	2,316			$	78			$	2,433			$	226

X

- Definition

Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (f)(2)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-1

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_TableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration